Malady Kyle 4
4 · VERIZON COMMUNICATIONS INC · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Verizon (VZ) EVP Kyle Malady Receives Phantom Stock Award
What Happened Kyle Malady, EVP and Group CEO—VZ Business, was granted 135.715 shares of phantom stock (reported as a derivative award) on June 4, 2026. The filing lists a per-share value of $12.81, for a total reported value of $1,739. This was an award/grant (code A), not an open-market purchase or sale.
Key Details
- Transaction date and price: 2026-06-04 at $12.81 per phantom share.
- Quantity and value: 135.715 phantom shares; total reported value $1,739.
- Shares owned after transaction: Not specified in this filing.
- Footnotes: F1 — each phantom share is cash-settled and payable upon events chosen under the deferred compensation plan; F2 — amount includes phantom stock acquired via dividend reinvestment.
- Filing timeliness: Report filed 2026-06-05 (one day after the transaction), appearing timely.
- Transaction code: A (award/grant of a derivative/phantom equity instrument).
Context Phantom stock is a cash-settled deferred compensation instrument that tracks the economic value of common shares but does not represent actual stock ownership until settled; payouts occur under plan rules and may be delayed for tax/deferral reasons. Such grants are typically routine compensation for executives and should not be interpreted as an open-market buy or sell signal.
Insider Transaction Report
- Award
Phantom Stock (unitized)
[F1][F2]2026-06-04$12.81/sh+135.715$1,739→ 417,277.945 total(indirect: By Deferred Compensation Plan)→ Common Stock (39 underlying)
Footnotes (2)
- [F1]Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.
- [F2]Includes phantom stock acquired through dividend reinvestment.